Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
IMMUTEP Ltd Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.	United States of America	IMMP
i-mobile Co.,Ltd. Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.	Japan	6535
INBIOGEN CO.,Ltd Data mining, bioinformatics, and virtual assistance for the life sciences industry.	South Korea	101140
Incannex Healthcare Inc. Develops oral cannabinoid/psychedelic therapies for sleep apnea, arthritis & anxiety.	United States of America	IXHL
Incross Co.,Ltd. A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.	South Korea	216050
INEST,Inc. Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.	Japan	7111
Innate Pharma Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.	France	IPH
Innovation Inc. Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.	Japan	3970
Innventure, Inc. Founds, funds, and scales companies using breakthrough R&D from multinational corporations.	United States of America	INV
Inotiv, Inc. CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.	United States of America	NOTV